Case Studies

2024-11-04

SARS-CoV-2 Spike Protein Expression & Purification | AtaGenix High-Yield Mammalian System

The results show that the SARS-CoV-2 S protein expressed in mammalian cells achieved high yields during purification, with clear target protein bands observed in elution fractions (E1-E8) and minimal impurities.

2024-10-21

XtenCHO™ High-Density Expression System

AtaGenix's XtenCHO™ high-density expression system demonstrates exceptional proliferation and yield advantages in therapeutic antibody production. Cells cultured in this system maintain high density and viability over 15 days, ensuring healthy growth. The system shows strong adaptability and production efficiency across various antibodies, providing robust support for efficient and stable therapeutic antibody manufacturing.